• OPEN AN ACCOUNT
Indian Indices
Sensex
85,666.49 477.89
( 0.56%)
Global Indices
Nasdaq
48,084.29 -303.78
(-0.63%)
Dow Jones
6,866.50 -50.74
(-0.73%)
Hang Seng
50,384.39 -142.53
(-0.28%)
Nikkei 225
9,931.38 -9.33
(-0.09%)
Forex
USD-INR
89.87 0.03
(0.03%)
EUR-INR
105.50 -0.18
(-0.17%)
GBP-INR
120.91 -0.28
(-0.23%)
JPY-INR
0.57 0.00
(-0.26%)

EQUITY - MARKET SCREENER

Rajnish Wellness Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541601
INE685Z01033
1.074797
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
53.81
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

ashok leyl& ltd
Ashok Leyland gains after December sales jump 27% YoY to 21,533 units
Jan 01,2026

Total domestic sales climbed 26% YoY to 19,885 units during the month. Domestic sales of medium and heavy commercial vehicles (M&HCV) grew 29% to 13,553 units, while light commercial vehicle (LCV) sales rose 21% to 6,302 units in December 2025 over the year-ago period.

Including exports, M&HCV sales increased 29% to 14,830 units, while LCV sales rose 22% to 6,703 units during the month.

Ashok Leyland is engaged in the manufacture and sale of a wide range of commercial vehicles. The company also manufactures engines for industrial and marine applications, forgings, and castings.

Ashok Leyland reported a marginal rise in standalone net profit to Rs 771.06 crore in Q2 FY26, compared to Rs 770.10 crore posted in Q2 FY25. Revenue from operations jumped 9.34% year-on-year (YoY) to Rs 9,588.18 crore for the quarter ended 30 September 2025.